index - CRCL-Apoptose, cancer et développement

Nicolas Braissand, Agnès Bernet. Cibler la nétrine-1 pour inhiber la transition épithélio-mésenchymateuse. Médecine/Sciences, 2024, 40 (2), pp.124-126. ⟨10.1051/medsci/2023207⟩. ⟨hal-04481126⟩
Joel D Pearson, Katherine Huang, Dela Pena, Benjamin Ducarouge, Patrick Mehlen, et al.. Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis. Cancer Research Communications, In press, ⟨10.1158/2767-9764.CRC-24-0101⟩. ⟨hal-04676524⟩
Sara Magliacane Trotta, Antonio Adinolfi, Luca D’orsi, Sonia Panico, Grazia Mercadante, et al.. Cancer-derived exosomal Alu RNA promotes colorectal cancer progression. Experimental & Molecular Medicine, In press, ⟨10.1038/s12276-024-01166-6⟩. ⟨hal-04523340⟩
Crissy Dudgeon, Anthony Casabianca, Chris Harris, Charline Ogier, Mélanie Bellina, et al.. Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling. Cell Reports, 2023, 42, ⟨10.1016/j.celrep.2023.113369⟩. ⟨hal-04382892⟩
Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, Ruxanda Chira, Aurélien Fonseca, et al.. Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor. Cell Death and Differentiation, 2023, 30 (10), pp.2201-2212. ⟨10.1038/s41418-023-01209-x⟩. ⟨hal-04253805⟩
Justine Lengrand, Ievgenia Pastushenko, Sebastiaan Vanuytven, Yura Song, David Venet, et al.. Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature, 2023, 620 (7973), pp.402-408. ⟨10.1038/s41586-023-06372-2⟩. ⟨hal-04238408⟩

Derniers manuscrits de l'équipe

Chiffres clés